Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

1

Egypt. J. Exp. Biol. (Zoo.). 2015; 11(2): 201-2011


TREATMENT WITH BONE MARROW PRODUCTS ACCELERATES RECOVERY FROM CHEMOTHERAPY ASSOCIATED LEUKOPENIA AND LIVER INJURY IN TUMOUR BEARING MICE

Mohamed L. Salem, Kadry A. EL-Bakry, Nahed A. Omer, Eman H. Moubark.

Abstract
Treatment with cyclophosphamide (CTX); a widely used anticancer drug, causes leukopenia which is the most critical associated side effect. The present work aimed to investigate the effects of treatment with bone marrow products on leukopenia and liver injury induced by CTX in Ehrlich ascetic carcinoma (EAC) mouse model. Adult female CD-1 mice were challenged with Ehrlich ascetic carcinoma (EAC) (2.5 x 105) cells on day 0 and then were inoculated 24 hours later with 100uL PBS or CTX (200 mg/kg) via intrapertioneal injection. The next day after CTX treatment, mice were treated for 5 consecutive days with granulocytes-colony stimulating factor (G-CSF; 250 g/kg) and/or bone marrow lysate (100 g/mouse) prepared from nave or CTX-treated mice via subcutaneous injection. Another groups of tumour-bearing mice were transferred with viable bone marrow cells (5 x 106) harvested from nave or CTX-treated mice. The results indicated that treatment with G-CSF induced recovery of the CTX-induced decreases in the numbers of bone marrow cells, splenocytes and peripheral blood leukocytes. While transfer of viable bone marrow cells resulted in recovery of bone marrow cell and spleen cell count only. Treatment of CTX-treated mice with bone marrow lysate prepared from nave or CTX-treated mice also induced recovery of the absolute number of lymphocytes. These effects were also associated with recovery from CTX-induced liver injury as observed by histopathological investigation. Of notes, treatment with bone marrow lysate prepared from nave or CTX-treated mice showed the highest recovery effects against CTX-induced lymphopenia. Finally, it is concluded that treatment with bone marrow products accelerates recovery of chemotherapy associated toxicity, opening a new avenue for further investigation to optimize their effects.

Key words: Blood, Bone marrow, Chemotherapy, Immune cells, Leukopenia, Lysate, Spleen.



Share this Article


Advertisement
Oxidants and Antioxidants in Medical Science

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons